Annual report pursuant to Section 13 and 15(d)

Document and Entity Information

v3.20.4
Document and Entity Information - USD ($)
$ in Millions
 12 Months Ended
Sep. 30, 2020
Dec. 21, 2020
Mar. 31, 2020
Document and Entity Information      
Document Type 10-K    
Document Period End Date Sep. 30, 2020    
Entity File Number 333-88480    
Entity Registrant Name NEUBASE THERAPEUTICS, INC.    
Entity Incorporation, State Code DE    
Title of 12(b) Security Common Stock, $0.0001 par value per share    
Trading Symbol NBSE    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity's Reporting Status Current Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Common Stock, Shares Outstanding   23,177,591  
Entity Public Float     $ 101
Entity Central Index Key 0001173281    
Current Fiscal Year End Date --09-30    
Document Fiscal Year Focus 2020    
Document Fiscal Period Focus FY    
Amendment Flag false